# Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

> **NCT00644475** · PHASE3 · UNKNOWN · sponsor: **University of Pavia** · enrollment: 60 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Imidapril
- **DRUG:** Candesartan

## Key facts

- **NCT ID:** NCT00644475
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2008-03
- **Final completion:** 2009-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644475, "Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00644475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*